Loading company…
Shenzhen-based XtalPi Inc. uses AI, quantum physics and big data to provide drug discovery and chemistry services.
Established in 2015 and based in Shenzhen, China, XtalPi Inc. combines quantum chemistry, artificial intelligence, big data and cloud computing for drug research and development. It offers drug discovery services for small and macromolecule drugs, chemistry services and laboratory automation, and works with several pharmaceutical companies. The company has more than 160 patents. It raised HKD 337.7 million in pre-IPO funding and listed on the Hong Kong Exchange and Clearing Ltd. in June 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in